“…Several decision rules were applied to specify the data to be included in effect size calculations: (a) data were included from studies identified as high quality (SCARF quality score ≥1.75, Chazin et al, 2021), (b) as many as the final five data points in baseline and intervention phases were included (consistent with Kahng et al, 2002, and Shawler et al, 2019), (c) for alternating treatment designs data from the most effective intervention were used, (d) for reversal or withdrawal designs only A-B phase contrasts were calculated (not B-A contrasts), only data sets with phase replication were included (e.g., ABAB, ABA, and BAB, Kahng et al, 2002), and those replications involving terminal versions of the intervention were included, (e) for changing criterion designs initial baseline and final phase data were included, (f) primary intervention data were used, exclusive of generalization or maintenance data, or data representing fading of the intervention’s original demand or reinforcement schedules, and (g) SIB data displayed inconsistently with the study design (and therefore unable to be extracted) were excluded.…”